Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Juliano Timm

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
The New England Journal of Medicine|January 11, 2023
Regimens for Drug-Resistant Tuberculosis. ReplyJuliano Timm, Angela M Crook, Eugene Sun
Nature Reviews. Drug Discovery|May 15, 2024
Combating antimicrobial resistance in malaria, HIV and tuberculosisMaëlle Duffey, Robert W Shafer, Juliano Timm, et al.
Infection and Immunity|December 25, 2004
Replication dynamics of Mycobacterium tuberculosis in chronically infected miceErnesto J Muñoz-Elías, Juliano Timm, Tania Botha, et al.
Infection and Immunity|October 24, 2003
Ribonucleotide reduction in Mycobacterium tuberculosis: function and expression of genes encoding class Ib and class II ribonucleotide reductasesStephanie S Dawes, Digby F Warner, Liana Tsenova, et al.
Antimicrobial Agents and Chemotherapy|March 16, 2016
MIC of Delamanid (OPC-67683) against Mycobacterium tuberculosis Clinical Isolates and a Proposed Critical ConcentrationKelly Stinson, Natalia Kurepina, Amour Venter, et al.
PLOS Global Public Health|October 18, 2023
Baseline and acquired resistance to bedaquiline, linezolid and pretomanid, and impact on treatment outcomes in four tuberculosis clinical trials containing pretomanidJuliano Timm, Anna Bateson, Priya Solanki, et al.
The Journal of Infectious Diseases|May 17, 2006
A multidrug-resistant, acr1-deficient clinical isolate of Mycobacterium tuberculosis is unimpaired for replication in macrophagesJuliano Timm, Natalia Kurepina, Barry N Kreiswirth, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 19, 2003
Differential expression of iron-, carbon-, and oxygen-responsive mycobacterial genes in the lungs of chronically infected mice and tuberculosis patientsJuliano Timm, Frank A Post, Linda-Gail Bekker, et al.
Annals of Clinical Microbiology and Antimicrobials|May 3, 2024
Prevalence and genetic basis of Mycobacterium tuberculosis resistance to pretomanid in ChinaBing Zhao, Huiwen Zheng, Juliano Timm, et al.
The New England Journal of Medicine|March 5, 2020
Treatment of Highly Drug-Resistant Pulmonary TuberculosisFrancesca Conradie, Andreas H Diacon, Nosipho Ngubane, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
The New England Journal of Medicine|January 11, 2023
Regimens for Drug-Resistant Tuberculosis. ReplyJuliano Timm, Angela M Crook, Eugene Sun
Nature Reviews. Drug Discovery|May 15, 2024
Combating antimicrobial resistance in malaria, HIV and tuberculosisMaëlle Duffey, Robert W Shafer, Juliano Timm, et al.
Infection and Immunity|December 25, 2004
Replication dynamics of Mycobacterium tuberculosis in chronically infected miceErnesto J Muñoz-Elías, Juliano Timm, Tania Botha, et al.
Infection and Immunity|October 24, 2003
Ribonucleotide reduction in Mycobacterium tuberculosis: function and expression of genes encoding class Ib and class II ribonucleotide reductasesStephanie S Dawes, Digby F Warner, Liana Tsenova, et al.
Antimicrobial Agents and Chemotherapy|March 16, 2016
MIC of Delamanid (OPC-67683) against Mycobacterium tuberculosis Clinical Isolates and a Proposed Critical ConcentrationKelly Stinson, Natalia Kurepina, Amour Venter, et al.
PLOS Global Public Health|October 18, 2023
Baseline and acquired resistance to bedaquiline, linezolid and pretomanid, and impact on treatment outcomes in four tuberculosis clinical trials containing pretomanidJuliano Timm, Anna Bateson, Priya Solanki, et al.
The Journal of Infectious Diseases|May 17, 2006
A multidrug-resistant, acr1-deficient clinical isolate of Mycobacterium tuberculosis is unimpaired for replication in macrophagesJuliano Timm, Natalia Kurepina, Barry N Kreiswirth, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 19, 2003
Differential expression of iron-, carbon-, and oxygen-responsive mycobacterial genes in the lungs of chronically infected mice and tuberculosis patientsJuliano Timm, Frank A Post, Linda-Gail Bekker, et al.
Annals of Clinical Microbiology and Antimicrobials|May 3, 2024
Prevalence and genetic basis of Mycobacterium tuberculosis resistance to pretomanid in ChinaBing Zhao, Huiwen Zheng, Juliano Timm, et al.
The New England Journal of Medicine|March 5, 2020
Treatment of Highly Drug-Resistant Pulmonary TuberculosisFrancesca Conradie, Andreas H Diacon, Nosipho Ngubane, et al.
Pageof 2